Salivary Glands

Breakthroughs in Gene Therapy and Tissue Engineering Reported

Published in Cancer Weekly, July 4th, 2000

The use of gene-transfer technology to repair salivary-gland tissue, allowing a pathway for saliva to flow, in patients undergoing radiation therapy for head and neck cancer, is possible in principle, according to Bruce J. Baum, DMD, PhD.

Baum, who is chief of the Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, U.S. National Institutes of Health, Bethesda, Maryland, spoke about the at the American Dental Association's National Media Conference, held June 15.

"We hypothesized that the major impediment to saliva flow from these irradiated, non-secreting cells was the absence of a pathway for water in their...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-07-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry